{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:53:21Z","timestamp":1791305601032,"version":"4.3.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ajo.2003.10.025","type":"journal-article","created":{"date-parts":[[2004,3,31]],"date-time":"2004-03-31T11:53:20Z","timestamp":1080734000000},"page":"615-624","source":"Crossref","is-referenced-by-count":19,"title":["Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration"],"prefix":"10.1016","volume":"137","author":[{"given":"Hilary L.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilarey R.F.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacque L.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2003.10.025_BIB1","series-title":"Age-Related Macular Degeneration","first-page":"31","article-title":"Epidemiology","author":"Klein","year":"1999"},{"key":"10.1016\/j.ajo.2003.10.025_BIB2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/bjo.85.3.261","article-title":"World blindness","volume":"85","author":"Taylor","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/oxfordjournals.aje.a117648","article-title":"Age-related macular degeneration is associated with atherosclerosis","volume":"142","author":"Vingerling","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB4","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/S0161-6420(97)30023-2","article-title":"The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy","volume":"104","author":"Klein","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.025_BIB5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0161-6420(02)01448-3","article-title":"The association of cardiovascular disease with the long-term incidence of age-related maculopathy","volume":"110","author":"Klein","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.025_BIB6","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archopht.1992.01080240041025","article-title":"Risk factors for neovascular age-related macular degeneration","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.aje.a116659","article-title":"The Beaver Dam Eye study","volume":"137","author":"Klein","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB8","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0161-6420(00)00409-7","article-title":"Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study","volume":"107","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.025_BIB9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0161-6420(00)00580-7","article-title":"Risk factors for age-related macular degeneration","volume":"108","author":"Smith","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.025_BIB10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archopht.119.10.1455","article-title":"Risk factors for age-related maculopathy","volume":"119","author":"McCarty","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archopht.120.10.1357","article-title":"Smoking and the 5-year incidence of age-related maculopathy","volume":"120","author":"Mitchell","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archopht.1982.01030030573002","article-title":"Cataracts and macular degeneration in older Americans","volume":"100","author":"Klein","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a112429","article-title":"The Framingham Eye study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart study","volume":"106","author":"Kahn","year":"1977","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archopht.1997.01100150743009","article-title":"Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.118.3.351","article-title":"Hypertension, cardiovascular disease, and age-related macular degeneration. Age-related Macular Degeneration Risk Factors Study Group","volume":"118","author":"Hyman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/archopht.1995.01100060069034","article-title":"Dietary fat and age-related maculopathy","volume":"113","author":"Mares-Perlman","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB17","first-page":"265","article-title":"Accumulation of cholesterol with age in human Bruch's membrane","volume":"42","author":"Curcio","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.025_BIB18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1076\/opep.6.2.125.1558","article-title":"Do age-related macular degeneration and cardiovascular disease share common antecedents?","volume":"6","author":"Snow","year":"1999","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB19","doi-asserted-by":"crossref","unstructured":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383\u20131389","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"10.1016\/j.ajo.2003.10.025_BIB20","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7\u201322","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"10.1016\/j.ajo.2003.10.025_BIB21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2003.10.025_BIB22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2003.10.025_BIB23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-119-10-199311150-00002","article-title":"Coronary angiographic changes with lovastatin therapy","volume":"119","author":"Blankenhorn","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajo.2003.10.025_BIB24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.89.3.959","article-title":"Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography","volume":"89","author":"Waters","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2003.10.025_BIB25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(94)92082-6","article-title":"Effect of simvastatin on coronary atheroma","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2003.10.025_BIB26","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.91.10.2528","article-title":"Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels","volume":"91","author":"Jukema","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2003.10.025_BIB27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0735-1097(95)00301-0","article-title":"Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I)","volume":"26","author":"Pitt","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.eurheartj.a015224","article-title":"The effect of simvastatin on progression of coronary artery disease","volume":"18","author":"Bestehorn","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajo.2003.10.025_BIB29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9149(97)00346-9","article-title":"Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])","volume":"80","author":"Herd","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","article-title":"The evolving role of statins in the management of atherosclerosis","volume":"35","author":"Vaughan","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB31","doi-asserted-by":"crossref","unstructured":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998\u20133007","DOI":"10.1001\/jama.288.23.2998"},{"key":"10.1016\/j.ajo.2003.10.025_BIB32","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/01.CIR.87.6.1781","article-title":"Lipid lowering and plaque regression","volume":"87","author":"Brown","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2003.10.025_BIB33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.CIR.104.3.249","article-title":"Effects of lipid-lowering by simvastatin on human atherosclerotic lesions","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2003.10.025_BIB34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1552-6569.2001.tb00034.x","article-title":"Possible short-term amelioration of basilar plaque by high-dose atorvastatin","volume":"11","author":"Callahan","year":"2001","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.ajo.2003.10.025_BIB35","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(98)00140-5","article-title":"New concepts and paradigms in cardiovascular medicine","volume":"104","author":"Gould","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ajo.2003.10.025_BIB36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(96)05190-2","article-title":"Statins do more than just lower cholesterol","volume":"348","author":"Vaughan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2003.10.025_BIB37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-8703(00)90033-4","article-title":"Statins","volume":"139","author":"Blumenthal","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ajo.2003.10.025_BIB38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.CIR.103.3.387","article-title":"Reduction of stroke events with pravastatin","volume":"103","author":"Byington","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2003.10.025_BIB39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2003.10.025_BIB40","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2003.10.025_BIB41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2003.10.025_BIB43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/rccm.200205-410OC","article-title":"Statin use is associated with improved function and survival of lung allografts","volume":"167","author":"Johnson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajo.2003.10.025_BIB44","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1046\/j.1523-1755.2001.00010.x","article-title":"Effect of fluvastatin on acute renal allograft rejection","volume":"60","author":"Holdaas","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajo.2003.10.025_BIB45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00007890-200107270-00009","article-title":"The effects of lipid-lowering agents on acute renal allograft rejection","volume":"72","author":"Kasiske","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ajo.2003.10.025_BIB46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1399-0012.2001.150305.x","article-title":"Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection","volume":"15","author":"Sahu","year":"2001","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ajo.2003.10.025_BIB47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ajo.2003.10.025_BIB48","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2003.10.025_BIB50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/CRIAI:23:3:263","article-title":"Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?","volume":"23","author":"Meroni","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5694\/j.1326-5377.2001.tb143604.x","article-title":"Cholesterol-lowering medications reduce the risk of age-related maculopathy progression","volume":"175","author":"McCarty","year":"2001","journal-title":"Med J Aust"},{"key":"10.1016\/j.ajo.2003.10.025_BIB52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/bmj.323.7309.375","article-title":"Risk of macular degeneration in users of statins","volume":"323","author":"Hall","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2003.10.025_BIB53","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/bmj.323.7324.1308a","article-title":"Risk of macular degeneration with statin use should be interpreted with caution","volume":"323","author":"van Leeuwen","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2003.10.025_BIB54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bjo.87.9.1121","article-title":"The association between statin use and age related maculopathy","volume":"87","author":"McGwin","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bmj.326.7383.255","article-title":"Cholesterol lowering drugs and risk of age related maculopathy","volume":"326","author":"van Leeuwen","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2003.10.025_BIB56","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archopht.121.8.1151","article-title":"Relation of statin use to the 5-year incidence and progression of age-related maculopathy","volume":"121","author":"Klein","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB57","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.1984.01040031330019","article-title":"Age-related macular degeneration and blindness due to neovascular maculopathy","volume":"102","author":"Ferris","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02150948","article-title":"Senile macular degeneration","volume":"223","author":"Penfold","year":"1985","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB59","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/eye.1990.86","article-title":"Macrophages related to Bruch's membrane in age-related macular degeneration","volume":"4","author":"Killingsworth","year":"1990","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2003.10.025_BIB60","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(14)77270-8","article-title":"Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration","volume":"112","author":"Lopez","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB61","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0161-6420(98)98014-9","article-title":"Choroidal neovascularization in the Choroidal Neovascularization Prevention trial","volume":"105","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.025_BIB62","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archopht.119.8.1191","article-title":"Dietary fat and risk for advanced age-related macular degeneration","volume":"119","author":"Seddon","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB63","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archopht.1991.01080090066027","article-title":"Subfoveal neovascular lesions in age-related macular degeneration","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0039-6257(05)80092-X","article-title":"An international classification and grading system for age-related maculopathy and age-related macular degeneration","volume":"39","author":"Bird","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB65","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0161-6420(95)30846-9","article-title":"Prevalence of age-related maculopathy in Australia","volume":"102","author":"Mitchell","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.025_BIB66","series-title":"Statistical models and methods for lifetime data","author":"Lawless","year":"1982"},{"key":"10.1016\/j.ajo.2003.10.025_BIB67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1076\/opep.8.4.237.1613","article-title":"Associations of cardiovascular disease and its risk factors with age-related macular degeneration","volume":"8","author":"Delcourt","year":"2001","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/archopht.121.4.519","article-title":"The risk and natural course of age-related maculopathy","volume":"121","author":"van Leeuwen","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB69","first-page":"1891","article-title":"The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes","volume":"40","author":"Oh","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.025_BIB70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000059634","article-title":"Detection of inducible nitric oxide synthase and vascular endothelial growth factor in choroidal neovascular membranes","volume":"216","author":"Hattenbach","year":"2002","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajo.2003.10.025_BIB71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1755.2003.00744.x","article-title":"Anti-inflammatory and immunomodulatory effects of statins","volume":"63","author":"Blanco-Colio","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajo.2003.10.025_BIB72","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1074\/jbc.M110870200","article-title":"Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis","volume":"277","author":"Qi","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2003.10.025_BIB73","first-page":"2194","article-title":"Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes","volume":"39","author":"Steen","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.025_BIB74","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-9394(99)00135-X","article-title":"Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration","volume":"128","author":"Kadonosono","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jmicro\/51.2.127","article-title":"Role of matrix metalloproteinase-7 in angiogenesis associated with age-related macular degeneration","volume":"51","author":"Yazama","year":"2002","journal-title":"J Electron Microsc (Tokyo)"},{"key":"10.1016\/j.ajo.2003.10.025_BIB76","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/PL00012505","article-title":"Statins","volume":"59","author":"Veillard","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ajo.2003.10.025_BIB77","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB78","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archopht.119.8.1143","article-title":"Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians","volume":"119","author":"Christen","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archopht.1986.01050160059012","article-title":"Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy","volume":"104","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB80","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/archopht.1990.01070080067037","article-title":"Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration","volume":"108","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB81","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1001\/jama.266.16.2279b","article-title":"Macular degeneration","volume":"266","author":"Klein","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2003.10.025_BIB82","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archopht.119.9.1354","article-title":"Medication use and the 5-year incidence of early age-related maculopathy","volume":"119","author":"Klein","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB83","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0161-6420(93)31634-9","article-title":"The relationship of cardiovascular disease and its risk factors to age-related maculopathy","volume":"100","author":"Klein","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2003.10.025_BIB84","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/ajcn\/57.3.428","article-title":"Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects","volume":"57","author":"Sanders","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajo.2003.10.025_BIB85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0009-8981(02)00288-7","article-title":"Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels?","volume":"326","author":"Abalain","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajo.2003.10.025_BIB86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000309370","article-title":"Association between drusen and some of the risk factors for coronary artery disease","volume":"188","author":"Vidaurri","year":"1984","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajo.2003.10.025_BIB87","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archopht.116.5.583","article-title":"Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy","volume":"116","author":"Smith","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2003.10.025_BIB88","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archopht.1994.01090150132035","article-title":"Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane","volume":"112","author":"Holz","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"Pt 6","key":"10.1016\/j.ajo.2003.10.025_BIB89","first-page":"674","article-title":"Retinal pigment epithelial detachments in the elderly","volume":"105","author":"Bird","year":"1986","journal-title":"Trans Ophthalmol Soc U K"},{"key":"10.1016\/j.ajo.2003.10.025_BIB90","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1086\/301901","article-title":"Genetic association of apolipoprotein E with age-related macular degeneration","volume":"63","author":"Klaver","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajo.2003.10.025_BIB91","first-page":"1891","article-title":"Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice","volume":"42","author":"Ong","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2003.10.025_BIB92","first-page":"2035","article-title":"Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice","volume":"41","author":"Dithmar","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939403012868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939403012868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T21:09:11Z","timestamp":1585688951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939403012868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0002939403012868"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2003.10.025","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}